The "valvulo-metabolic" risk in calcific aortic valve disease

Authors: Mathieu, PatrickDesprés, Jean-PierrePibarot, Philippe
Other Title(s): Le risque "valvulométabolique" dans la valvulopathie calcifiée
Abstract: Calcific aortic stenosis (AS) has been considered a degenerative and unmodifiable process resulting from aging and ‘wear and tear’ of the aortic valve. Over the past decade, studies in the field of epidemiology, molecular biology and lipid metabolism have highlighted similarities between vascular atherosclerosis and calcific AS. In particular, work from the Quebec Heart Institute and from that of others has documented evidence of valvular infiltration by oxidized low-density lipoproteins and the presence of inflammatory cells, along with important tissue remodelling in valves explanted from patients with AS. Recent studies have also emphasized the role of visceral obesity in the development and progression of AS. In addition, visceral obesity, with its attendant metabolic complications, commonly referred to as the metabolic syndrome, has been associated with degenerative changes in bioprosthetic heart valves. The purpose of the present review is to introduce the concept of ‘valvulo-metabolic risk’ and to provide an update on the recent and important discoveries regarding the pathogenesis of heart valve diseases in relation to obesity, and to discuss how these novel mechanisms might translate into clinical practice.
Document Type: Article de recherche
Issue Date: October 2007
Open Access Date: Restricted access
Document version: VoR
This document was published in: The Canadian journal of cardiology, Vol. 23, suppl. B, p. 32B–39B (2007)
Canadian journal of cardiology
Alternative version: 10.1016/S0828-282X(07)71008-5
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
245.17 kBAdobe PDF    Request a copy
All documents in CorpusUL are protected by Copyright Act of Canada.